Premium domain name for sale

ActiveStent.com

The right name for the next generation of electronic venous stents: devices that do more than hold a vein open.

Smart stentsA venous stent combined with sensors and electronics.
Active functionDetect and, in concept, destroy harmful cells in the blood.
One clear nameActiveStent.com says exactly what the product is.

The idea in plain English

A stent is a small mesh tube placed inside a blood vessel. Normally it is passive: it simply holds the vessel open. An active stent adds electronics, so the device can sense what passes through it and respond.

The best-known example comes from oncologist Dr Azra Raza of Columbia University. She describes a device called the Stentinel (sentinel + stent), developed with biomedical engineers at Columbia. Her descriptions say it would sit in a vein, continuously scan the bloodstream for the earliest cancer cells and biomarkers, and could be programmed to destroy them with an electrical pulse.

Why the potential is exciting

Catching disease at the very start

Dr Raza’s “first cell” approach aims to find and remove cancer before it multiplies, instead of chasing advanced disease. She describes detection at “Stage Negative One”.

Continuous watching, not occasional tests

A stent in the bloodstream could monitor around the clock, rather than relying on a scan or blood test at a single moment.

Detection and response in one device

The concept combines sensing with a built-in electrical response, so the same implant that finds a suspect cell could act on it.

Built on a familiar medical device

Stents are routine in medicine. Starting from one may help with safety thinking and manufacturing, though a new electronic version would still need its own evidence and approval.

Potential for low cost and wide access

Dr Raza has said the aim is for the stent to be affordable, quoting a figure of about $80, so that it is not a luxury for the rich.

A wider field is forming

Other teams are building stents with wireless sensors for blood pressure and flow, and “electronic blood vessels” that carry circuitry. Electrical pulses are already used to destroy tumour cells in a technique called irreversible electroporation. A far older patent describes electrodes in the veins to treat blood-borne viruses.

A realistic view. The Stentinel is a development-stage concept, not an approved treatment or a cure for cancer. Published reports describe a target of availability around 2028 and a biological rationale based on unusually large circulating cells. That finding does not by itself show the device can detect or eliminate cancer. Dr Raza’s work concerns cancer cells; it is not specifically about bacteria or viruses.

This page is a marketing summary prepared from public sources. It is not medical advice or a statement about any product’s safety or effectiveness.

Why the right domain name matters

In medical devices, trust is everything. Clinicians, investors, partners and regulators look at a company’s name and web address before they read anything else. A weak or confusing address makes a serious technology look improvised.

Who it suits

Medical device manufacturers, start-ups and university spin-outs working on electronic or sensing stents, cardiovascular and oncology technology companies, and investors building a brand around active implants.

ActiveStent.com is available. To make an offer or ask about leasing, please enquire through URLease.com.

Independent listing. Not affiliated with, or endorsed by, Dr Azra Raza, Columbia University or any company named on this page. Buyers should carry out their own trademark and due-diligence checks.

Sources